Real-world use of brexpiprazole during inpatient treatment for schizophrenia: continuation, discontinuation, and concomitant psychotropics

IntroductionIn the treatment of schizophrenia, antipsychotics used during acute inpatient care must control acute symptoms while remaining sufficiently tolerable to support treatment beyond the acute phase. Brexpiprazole, a serotonin-dopamine activity modulator may be one such option; however, its r...

Повний опис

Збережено в:

Бібліографічні деталі
Автори:	Yuki Noriyama, Shintaro Araki, Ryohei Takada, Hiroaki Fukui, Yuya Honda, Kazuki Okumura, Yuki Nishi, Minobu Ikehara, Takashi Okada
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2026-05-01
Серія:	Frontiers in Psychiatry
Предмети:	brexpiprazole concomitant medications discontinuation inpatient real-world evidence schizophrenia
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fpsyt.2026.1829496/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Real-world use of brexpiprazole during inpatient treatment for schizophrenia: continuation, discontinuation, and concomitant psychotropics

Схожі ресурси